Ligand density at the surface of a nanoparticle and different uptake mechanism: two important factors for successful siRNA delivery to liver endothelial cells
- PMID: 25169077
- DOI: 10.1016/j.ijpharm.2014.08.048
Ligand density at the surface of a nanoparticle and different uptake mechanism: two important factors for successful siRNA delivery to liver endothelial cells
Abstract
The specific delivery of a gene to liver sinusoidal endothelial cells (LSEC) could become a useful strategy for treating various liver diseases associated with such cells. We previously reported that the accumulation of KLGR peptide modified liposomes through liver sinusoidal blood vessels was enhanced after an intravenous administration. Here, we report on an attempt to develop an LSEC targeted nanocarrier system to deliver siRNA for the successful knockdown of LSEC specific gene expression. The system involved the development of a multifunctional envelop-type nano device (MEND) modified with the KLGR peptide for siRNA delivery targeting LSEC. Our developed carrier successfully lowered specific gene expression in LSEC. An in vivo study showed that at a lower density of ligand at the surface of the MEND resulted in the highest knockdown of gene expression in LSEC. This is the first report of the successful delivery of siRNA to LSECs. Further experiments suggest that not only a higher endosomal escape efficiency into the cytosol but also the uptake mechanism as a function of ligand density are two important factors to be considered for targeting LSEC.
Keywords: ApoB 100; KLGR peptide; Liver sinusoidal endothelial cell; siRNA.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells.Int J Pharm. 2014 Apr 25;465(1-2):77-82. doi: 10.1016/j.ijpharm.2014.02.016. Epub 2014 Feb 12. Int J Pharm. 2014. PMID: 24530390
-
A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.J Control Release. 2008 Jan 22;125(2):164-73. doi: 10.1016/j.jconrel.2007.10.020. Epub 2007 Nov 4. J Control Release. 2008. PMID: 18054812
-
Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.Bioconjug Chem. 2015 Jul 15;26(7):1266-76. doi: 10.1021/acs.bioconjchem.5b00184. Epub 2015 Jun 5. Bioconjug Chem. 2015. PMID: 25938819 Review.
-
Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.Biomaterials. 2011 Jun;32(18):4306-16. doi: 10.1016/j.biomaterials.2011.02.045. Epub 2011 Mar 22. Biomaterials. 2011. PMID: 21429576
-
Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.J Control Release. 2015 Apr 10;203:1-15. doi: 10.1016/j.jconrel.2015.02.003. Epub 2015 Feb 4. J Control Release. 2015. PMID: 25660205 Review.
Cited by
-
Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance.Nanomaterials (Basel). 2023 Dec 26;14(1):67. doi: 10.3390/nano14010067. Nanomaterials (Basel). 2023. PMID: 38202522 Free PMC article. Review.
-
Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials.Drug Deliv Transl Res. 2022 Sep;12(9):2048-2074. doi: 10.1007/s13346-022-01147-0. Epub 2022 May 4. Drug Deliv Transl Res. 2022. PMID: 35507131 Free PMC article. Review.
-
Polymeric nanomedicines for the treatment of hepatic diseases.J Nanobiotechnology. 2022 Nov 19;20(1):488. doi: 10.1186/s12951-022-01708-y. J Nanobiotechnology. 2022. PMID: 36402994 Free PMC article. Review.
-
Engineering nanoparticles to overcome barriers to immunotherapy.Bioeng Transl Med. 2016 Jun 20;1(1):47-62. doi: 10.1002/btm2.10005. eCollection 2016 Mar. Bioeng Transl Med. 2016. PMID: 29313006 Free PMC article. Review.
-
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.Clin Immunol. 2015 Sep;160(1):14-23. doi: 10.1016/j.clim.2015.03.013. Epub 2015 Mar 21. Clin Immunol. 2015. PMID: 25805659 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous